食管受照剂量长度与肺癌放疗患者体重下降的关系
该回顾性研究纳入214例接受根治性常规分割放疗的肺癌患者,探讨食管剂量-长度参数(Ldose)能否预测放疗期间显著体重下降(较放疗前下降≥5%)。多因素分析显示,食管高全周剂量长度(LF50-LF60)和高部分周剂量长度(LP60)与显著体重下降相关(P≤.05),且LF65>LF60>LP65是决定体重下降的最重要剂量参数。
要点
- 食管LF50-LF60和LP60与放疗期间显著体重下降相关(P≤.05)。
- LF65>LF60>LP65是决定体重下降的最重要剂量参数。
- 食管Ldose参数可高效解读复杂剂量参数与体重下降毒性的关系。
核心结论
- 食管Ldose参数是解读肺癌根治性放疗患者复杂剂量参数与体重下降毒性关系的有效方式。
研究设计与样本
- 回顾性识别2010至2018年间接受常规分割放疗的肺癌患者,共纳入214例。
主要发现
- 食管高全周剂量长度LF50-LF60和高部分周剂量长度LP60与显著体重下降相关(P≤.05)。
- LF65和LP65接近显著性(P=.06和.053)。
- LF65>LF60>LP65是决定体重下降的最重要剂量参数。
关键数值与推荐
- 显著体重下降定义为放疗期间较放疗前体重下降≥5%。
- 全周和部分周食管长度分别定义为接受大于阈值剂量(Gy)的食管长度。
临床怎么用
- 可利用食管Ldose参数评估肺癌根治性放疗患者体重下降风险。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We investigate whether esophageal dose-length parameters (Ldose) can robustly predict significant weight loss-≥5% weight loss during radiation therapy (RT) compared with the weight before RT-in patients with lung cancer treated with definitive intent. METHODS AND MATERIALS: Patients with lung cancer treated with conventionally fractionated RT between 2010 and 2018 were retrospectively identified. LFdose and LPdose, the length of full- and partial-circumferential esophagus receiving greater than a threshold dose in Gy, respectively, were created. Multivariate logistic regression examined the associations between individual Ldose and weight loss after adjusting for clinical parameters and correcting for multiple comparisons. Ridge logistic regression examined the relative importance of Ldose compared with dose-volume (Vdose), mean dose (Dmean), and clinical parameters in determining weight loss. Univariate logistic regression examined the unadjusted probability of weight loss for important Ldose parameters. RESULTS: Among the 214 patients identified, median age was 66.9 years (range, 31.5-88.9 years), 50.5% (n = 108) were male, 68.2% (n = 146) had stage III lung cancer, median RT dose was 63 Gy (range, 60-66 Gy), and 88.3% (n = 189) received concurrent chemotherapy. Esophagus lengths receiving high full-circumferential (LF50-LF60) and high partial-circumferential doses (LP60) were associated with significant weight loss (P ≤ .05). LF65 and LP65 reached near significance (P = .06 and .053, respectively). LF65 > LF60 > LP65 were the most important dose parameters in determining weight loss compared with other Ldose, Vdose, and Dmean parameters. CONCLUSIONS: Esophageal Ldose parameters are an efficient way of interpreting complex dose parameters in relation to weight loss toxicity among patients with lung cancer receiving definitive RT.
引用
- Han P, Hales R, Lakshminarayanan P, et al. Exploring the Relationship of Radiation Dose Exposed to the Length of Esophagus and Weight Loss in Patients with Lung Cancer. Pract Radiat Oncol. 2020. PMID: 32201321. doi:10.1016/j.prro.2020.03.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。